Mankind Pharma Ltd (MANKIND) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.022x

Based on the latest financial reports, Mankind Pharma Ltd (MANKIND) has a cash flow conversion efficiency ratio of 0.022x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.93 Billion ≈ $20.87 Million USD) by net assets (Rs86.34 Billion ≈ $933.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Mankind Pharma Ltd (MANKIND) liquidity interval to measure how many days the company can operate on defensive assets alone.

Mankind Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Mankind Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mankind Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mankind Pharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
RAKUTEN GROUP SPONS.ADR 1 F:RAKA	0.382x
Kratos Defense & Security Solutions NASDAQ:KTOS	-0.008x
Pentair plc F:PNT	-0.018x
Fox Corp Class B NASDAQ:FOX	0.172x
Antero Resources Corp NYSE:AR	0.104x
Ipsen SA PA:IPN	0.125x
Yangzijiang Shipbuilding (Holdings) Ltd F:B8O	0.034x
Insurance Australia Group Limited F:NRM	0.010x

Annual Cash Flow Conversion Efficiency for Mankind Pharma Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of Mankind Pharma Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see MANKIND stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs145.68 Billion ≈ $1.58 Billion	Rs24.13 Billion ≈ $261.00 Million	0.166x	-26.30%
2024-03-31	Rs95.76 Billion ≈ $1.04 Billion	Rs21.52 Billion ≈ $232.78 Million	0.225x	-5.18%
2023-03-31	Rs76.49 Billion ≈ $827.19 Million	Rs18.13 Billion ≈ $196.10 Million	0.237x	+62.80%
2022-03-31	Rs63.16 Billion ≈ $683.08 Million	Rs9.20 Billion ≈ $99.47 Million	0.146x	-37.73%
2021-03-31	Rs48.63 Billion ≈ $525.90 Million	Rs11.37 Billion ≈ $122.99 Million	0.234x	-19.73%
2020-03-31	Rs36.72 Billion ≈ $397.07 Million	Rs10.70 Billion ≈ $115.68 Million	0.291x	+44.69%
2019-03-31	Rs29.82 Billion ≈ $322.46 Million	Rs6.00 Billion ≈ $64.93 Million	0.201x	--

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$10.52 Billion

Rs972.65 Billion INR

Market Cap Rank

#2186 Global

#87 in India

Share Price

Rs2356.20

Change (1 day)

-1.01%

52-Week Range

Rs1927.40 - Rs2696.50

All Time High

Rs2998.40